Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Oct 6, 2024; 12(28): 6195-6203
Published online Oct 6, 2024. doi: 10.12998/wjcc.v12.i28.6195
Table 7 Comparison of the incidence of adverse reactions after intravenous injection of ketamine in three groups, n (%)
Adverse reaction
Administration time
Low-dose group (n = 97)
How-dose group (n = 97)
Control group (n = 98)
χ2 value
P value
Nausea & vomiting0-2 h2 (2.1)2 (2.1)3 (3.1)0.2780.870
Headache0-2 h0 (0)2 (2.1)0 (0)4.0480.132
Hallucination0-2 h2 (7.2)a9 (9.3)a,b0 (0)8.9490.011
Dizziness0-2 h7 (7.2)7 (7.2)2 (2.0)3.3680.186
Drowsiness0-2 h6 (10.3)a17 (17.5)a,b0 (0)18.039< 0.001
Diplopia0-2 h2 (8)a9 (9.3)a,b0 (0)9.2130.010
Shivering0-2 h5 (5.2)3 (3.1)6 (6.1)1.0220.600
Itching0-2 h0 (0)3 (3.1)2 (2.0)2.8510.240
Reaction delay0-2 h3 (3.1)3 (3.1)0 (0)3.0950.213